NR3C2 and colonic neoplasm: [36] Indeed we demonstrated that re-expressed and agonist-activated MR reduced VEGFA mRNA expression in colon cancer cells even when maximally activated by their exposure to lower oxygen concentration or CoCl2 treatment.